Sign in
4

Changes in Ownership

Maze Therapeutics, Inc. Filed Acc 0001415889-25-002957

Director acquired 307,956 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Lim Jonathan E Director 2025-02-03 Conversion +37,724 37,724 I: show line 1 in the form
Lim Jonathan E Director 2025-02-03 Conversion +270,232 307,956 I: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Lim Jonathan E Director 2025-02-03 Conversion · Series A Preferred Stock −363,703 0 I: show line 3 in the form
Lim Jonathan E Director 2025-02-03 Conversion · Series B Preferred Stock −2,231,381 0 I: show line 4 in the form
Lim Jonathan E Director 2024-12-09 Grant or award · Stock Option (Right to Buy) +5,704 5,704 D: show line 5 in the form
Lim Jonathan E Director 2024-12-09 Returned to the company · Stock Option (Right to Buy) −5,704 0 D: show line 6 in the form
Lim Jonathan E Director 2024-12-09 Grant or award · Stock Option (Right to Buy) +9,086 9,086 D: show line 7 in the form
Loading xslF345X05/form4-02042025_090248.xml…